Company profile: Retractable Technologies
1.1 - Company Overview
Company description
- Provider of safety medical products for the healthcare profession, focused on automated needle retraction to reduce needlestick injuries. Offerings include VanishPoint syringes (including U-100 insulin), blood collection sets and tube holders, IV catheters, and EasyPoint retractable needles, with one-handed or in‑vein activation, accurate dose delivery, and reduced disposal space.
Products and services
- VanishPoint Blood Collection Set: In-vein-retraction assembly delivers automated, one-handed activation that retracts the needle inside the vein to reduce needlestick injuries during blood collection
- VanishPoint IV Catheter: Automated-retraction catheter enables one-handed activation without additional components, streamlining IV catheterization procedures with fewer parts and simpler handling
- VanishPoint Syringe: Automated-retraction design retracts the needle to reduce needlestick injuries and requires less disposal space, optimizing injection safety and waste management in clinical workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Retractable Technologies
Novosanis
HQ: Belgium
Website
- Description: Provider of medical devices enhancing accuracy of diagnostic tests and drug delivery, focused on prevention, detection and treatment of infectious diseases and oncology. Products include Colli-Pee, a urine collection device enabling volumetric, standardized first-void sampling to improve detection of infectious diseases and some cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novosanis company profile →
Cure Pharmaceutical
HQ: United States
Website
- Description: Provider of specialty pharmaceutical and bioscience drug formulation and delivery technologies, featuring the CUREfilm thin-film platform for sublingual and buccal delivery. Offerings include CUREfilm Blue (sildenafil for ED), oral thin-film insulin, CU-2025g for weight management, an oral Hepatitis B vaccine, and CUREfilm-based nutraceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cure Pharmaceutical company profile →
Flat Medical
HQ: United States
Website
- Description: Provider of safety technology solutions for clinical procedures, including EpiFaith Syringe, an epidural space locating syringe that provides real-time, objective pressure information with a visual signal to ensure safer procedures, and EpiFaith CV, a syringe for central venous catheterization featuring auto-aspiration and pressure-detecting mechanisms to improve needle control and reduce the risk of arterial puncture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flat Medical company profile →
Softhale
HQ: Belgium
Website
- Description: Provider of soft mist inhalation (SMI) devices, including an innovative handheld non-thermal mechanical nebulizer, enabling effective respiratory delivery of pharmaceutical drugs to the lungs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Softhale company profile →
Emisphere Technologies
HQ: United States
Website
- Description: Provider of proprietary Eligen Technology to develop new oral formulations of therapeutic agents, enhancing absorption of drugs typically administered via injection. A pharmaceutical company with multiple product candidates in clinical development and several in pre-clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emisphere Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Retractable Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Retractable Technologies
2.2 - Growth funds investing in similar companies to Retractable Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Retractable Technologies
4.2 - Public trading comparable groups for Retractable Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →